Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11671 | 899 | 39.6 | 70% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1407 | 7566 | GUILLAIN BARRE SYNDROME//CASTLEMANS DISEASE//POEMS SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | EXPERIMENTAL AUTOIMMUNE NEURITIS | Author keyword | 79 | 61% | 9% | 83 |
| 2 | EXPERIMENTAL ALLERGIC NEURITIS | Author keyword | 63 | 76% | 5% | 44 |
| 3 | EXPERIMENTAL AUTOIMMUNE NEURITIS EAN | Author keyword | 15 | 82% | 1% | 9 |
| 4 | P2 PROTEIN | Author keyword | 9 | 67% | 1% | 8 |
| 5 | MYELIN PHAGOCYTOSIS | Author keyword | 8 | 56% | 1% | 10 |
| 6 | NEUROMUSCULAR IMMUNOPATHOL | Address | 8 | 62% | 1% | 8 |
| 7 | WALLERIAN DEGENERATION | Author keyword | 7 | 12% | 6% | 58 |
| 8 | CLAI | Address | 7 | 67% | 1% | 6 |
| 9 | GERIATR MED B84 | Address | 6 | 50% | 1% | 8 |
| 10 | EAN | Author keyword | 5 | 33% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | EXPERIMENTAL AUTOIMMUNE NEURITIS | 79 | 61% | 9% | 83 | Search EXPERIMENTAL+AUTOIMMUNE+NEURITIS | Search EXPERIMENTAL+AUTOIMMUNE+NEURITIS |
| 2 | EXPERIMENTAL ALLERGIC NEURITIS | 63 | 76% | 5% | 44 | Search EXPERIMENTAL+ALLERGIC+NEURITIS | Search EXPERIMENTAL+ALLERGIC+NEURITIS |
| 3 | EXPERIMENTAL AUTOIMMUNE NEURITIS EAN | 15 | 82% | 1% | 9 | Search EXPERIMENTAL+AUTOIMMUNE+NEURITIS+EAN | Search EXPERIMENTAL+AUTOIMMUNE+NEURITIS+EAN |
| 4 | P2 PROTEIN | 9 | 67% | 1% | 8 | Search P2+PROTEIN | Search P2+PROTEIN |
| 5 | MYELIN PHAGOCYTOSIS | 8 | 56% | 1% | 10 | Search MYELIN+PHAGOCYTOSIS | Search MYELIN+PHAGOCYTOSIS |
| 6 | WALLERIAN DEGENERATION | 7 | 12% | 6% | 58 | Search WALLERIAN+DEGENERATION | Search WALLERIAN+DEGENERATION |
| 7 | EAN | 5 | 33% | 1% | 13 | Search EAN | Search EAN |
| 8 | GALECTIN 3 MAC 2 | 2 | 67% | 0% | 2 | Search GALECTIN+3+MAC+2 | Search GALECTIN+3+MAC+2 |
| 9 | ISOGENIC MICE | 2 | 50% | 0% | 3 | Search ISOGENIC+MICE | Search ISOGENIC+MICE |
| 10 | AUTOIMMUNE NEURITIS | 2 | 43% | 0% | 3 | Search AUTOIMMUNE+NEURITIS | Search AUTOIMMUNE+NEURITIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXPERIMENTAL ALLERGIC NEURITIS | 116 | 45% | 22% | 194 |
| 2 | EXPERIMENTAL AUTOIMMUNE NEURITIS | 48 | 42% | 10% | 87 |
| 3 | IDIOPATHIC DEMYELINATING POLYRADICULONEUROPATHY | 32 | 85% | 2% | 17 |
| 4 | IMMUNE MEDIATED DEMYELINATION | 22 | 47% | 4% | 35 |
| 5 | MYELIN PHAGOCYTOSIS | 16 | 48% | 3% | 25 |
| 6 | BLOCKS MYELIN PHAGOCYTOSIS | 14 | 100% | 1% | 7 |
| 7 | MILLIPORE DIFFUSION CHAMBERS | 11 | 100% | 1% | 6 |
| 8 | RESIDENT ENDONEURIAL MACROPHAGES | 7 | 67% | 1% | 6 |
| 9 | MOUSE PERIPHERAL NERVE | 6 | 100% | 0% | 4 |
| 10 | MYELIN DEGRADATION | 5 | 50% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The role of macrophages in immune-mediated damage to the peripheral nervous system | 2001 | 138 | 200 | 48% |
| The role of macrophages in Wallerian degeneration | 1997 | 154 | 114 | 42% |
| Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury | 2011 | 86 | 151 | 23% |
| Interactions Between Schwann Cells and Macrophages in Injury and Inherited Demyelinating Disease | 2008 | 70 | 111 | 32% |
| Why is Wallerian degeneration in the CNS so slow? | 2007 | 157 | 182 | 18% |
| Molecular Inflammatory Mediators in Peripheral Nerve Degeneration and Regeneration | 2010 | 30 | 126 | 33% |
| Wallerian degeneration: the innate-immune response to traumatic nerve injury | 2011 | 54 | 140 | 28% |
| Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome | 1998 | 75 | 95 | 51% |
| Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis | 2013 | 9 | 140 | 34% |
| The neuroinflammatory role of Schwann cells in disease | 2013 | 10 | 111 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEUROMUSCULAR IMMUNOPATHOL | 8 | 62% | 0.9% | 8 |
| 2 | CLAI | 7 | 67% | 0.7% | 6 |
| 3 | GERIATR MED B84 | 6 | 50% | 0.9% | 8 |
| 4 | GRP CLIN EXPT NEUROIMMUNOL | 2 | 33% | 0.7% | 6 |
| 5 | CLIN GRP MULTIPLE SCLEROSIS NEUROIMMUNOL | 1 | 13% | 1.0% | 9 |
| 6 | CLIN UNIT MULTIPLE SCLEROSIS | 1 | 33% | 0.2% | 2 |
| 7 | GRP NERF MUSCLE | 1 | 33% | 0.2% | 2 |
| 8 | CONICETIFIBYNE | 1 | 50% | 0.1% | 1 |
| 9 | MEDCOLONIA MITRAS | 1 | 50% | 0.1% | 1 |
| 10 | NEUROL MOORENSTR 5 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000184452 | GUILLAIN BARRE SYNDROME//MILLER FISHER SYNDROME//ACUTE MOTOR AXONAL NEUROPATHY |
| 2 | 0.0000175806 | SCHWANN CELL//CHRONIC NERVE COMPRESSION INJURY//HUMANANAT EMBRYOL |
| 3 | 0.0000138753 | MULTIFOCAL MOTOR NEUROPATHY//CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY//CIDP |
| 4 | 0.0000104440 | RGC 32//RESPONSE GENE TO COMPLEMENT 32//BIIG |
| 5 | 0.0000095604 | PERINEURIUM//BLOOD NERVE INTERFACE//ENDONEURIAL FLUID |
| 6 | 0.0000079339 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS |
| 7 | 0.0000067492 | CELL BIOL IMMUNOL SECT//HUMAN NEURAL DEVELOPMENT//LEWIS THOMAS S 123 |
| 8 | 0.0000063442 | LINOMIDE//ROQUINIMEX//LAQUINIMOD |
| 9 | 0.0000061890 | WLDS//NMNAT//NAD BIOSYNTHESIS |
| 10 | 0.0000060141 | SFAS APO 1//ACUTE RELAPSE//AMYLOID PEPTIDE A BETA |